TY - JOUR
T1 - Correction
T2 - A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer (British Journal of Cancer, (2019), 120, 2, (183-189), 10.1038/s41416-018-0343-z)
AU - Gorbunova, Vera
AU - Beck, J. Thaddeus
AU - Hofheinz, Ralf Dieter
AU - Garcia-Alfonso, Pilar
AU - Nechaeva, Marina
AU - Gracian, Antonio Cubillo
AU - Mangel, Laszlo
AU - Fernandez, Elena Elez
AU - Deming, Dustin A.
AU - Ramanathan, Ramesh K.
AU - Torres, Alison H.
AU - Sullivan, Danielle
AU - Luo, Yan
AU - Berlin, Jordan D.
N1 - Publisher Copyright:
© 2019, The Author(s).
PY - 2019/8/27
Y1 - 2019/8/27
N2 - The original version of this article contained an error in Figure 1a. The number of patients at risk listed in the Veliparib arm of Figure 1a should have read “65” instead of “35”. An amendment to this paper has been published and can be accessed via a link at the top of the paper.
AB - The original version of this article contained an error in Figure 1a. The number of patients at risk listed in the Veliparib arm of Figure 1a should have read “65” instead of “35”. An amendment to this paper has been published and can be accessed via a link at the top of the paper.
UR - http://www.scopus.com/inward/record.url?scp=85069717633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069717633&partnerID=8YFLogxK
U2 - 10.1038/s41416-019-0528-0
DO - 10.1038/s41416-019-0528-0
M3 - Comment/debate
C2 - 31350526
AN - SCOPUS:85069717633
SN - 0007-0920
VL - 121
SP - 429
EP - 430
JO - British journal of cancer
JF - British journal of cancer
IS - 5
ER -